Status:
COMPLETED
Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative Colitis
Lead Sponsor:
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Conditions:
IBD-Inflammatory Bowel Disease
UC - Ulcerative Colitis
Eligibility:
All Genders
18-99 years
Brief Summary
This study is therefore postulated as a clear alternative that evaluates patients´quality of life, and recognises fecal calprotectin as an inflammatory marker. Longitudinal, prospective, multi-center...
Detailed Description
Research justification: There is not enough evidence on the effect of therapeutic intervention implemented by doctors in patients with IBD, depending on the rate of mucosal healing at colonoscopy. Fr...
Eligibility Criteria
Inclusion
- UC diagnosed.
- Age ≥ 18.
- Signed and dated informed consent form.
- Have undergone a Mayo 0 or 1 endoscopic score colonoscopy while in clinical remission.
Exclusion
- Incomplete colonoscopy.
- Previous bowel resection.
- Ostomy patient.
- Active infection.
- Pregnancy.
- Lack of patient's informed consent.
Key Trial Info
Start Date :
November 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2025
Estimated Enrollment :
234 Patients enrolled
Trial Details
Trial ID
NCT05271773
Start Date
November 18 2022
End Date
November 30 2025
Last Update
December 2 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Marqués de Valdecilla
Santander, Cantabria, Spain, 39008
2
Hospital Universitari Parc Taulí
Sabadell, Catalonia, Spain, 08208
3
Hospital de Santa Bárbara de Puertollano
Puertollano, Ciudad Real, Spain, 13500
4
Hospital Universitario de Cáceres
Cáceres, Extremadura, Spain, 10004